Par Drugs & Che.

Market Cap: Micro Cap
Industry: Chemicals & Petrochemicals
ISIN: INE04LG01015
NSEID: PAR
BSEID:

INR

110.81

5.7 (5.42%)

BSENSE

Dec 19

BSE+NSE Vol: 119953

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Par Drugs & Che.

Jocil

Sanginita Chemi.

Hindcon Chemical

Vadivarhe Speci.

Indian Phosphate

Vital Chemtech

Mahickra Chem.

Paragon Fine

Ushanti Colour

Unilex Colour &C

Why is Par Drugs & Chemicals Ltd ?

Poor long term growth as Operating profit has grown by an annual rate -7.45% of over the last 5 years

Flat results in Sep 25

PAT(9M) At Rs 9.11 cr has Grown at -38.65%

With ROE of 9.8, it has a Expensive valuation with a 1.4 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -100.00%, its profits have fallen by -47%

Below par performance in long term as well as near term

Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Par Drugs & Che. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Par Drugs & Che.

-48.57%

-1.11

43.66%

Sensex

7.21%

0.61

11.73%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.46%

EBIT Growth (5y)

-7.45%

EBIT to Interest (avg)

15.56

Debt to EBITDA (avg)

0.39

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

1.14

Tax Ratio

25.92%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

30.53%

ROE (avg)

15.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.38

EV to EBIT

11.09

EV to EBITDA

8.07

EV to Capital Employed

1.52

EV to Sales

1.11

PEG Ratio

Dividend Yield

ROCE (Latest)

22.22%

ROE (Latest)

9.79%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

PBT LESS OI(Q)

At Rs 5.07 cr has Grown at 34.3% (vs previous 4Q average

-4What is not working for the Company

PAT(9M)

At Rs 9.11 cr has Grown at -38.65%

Loading Valuation Snapshot...

Here's what is working for Par Drugs & Che.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 5.07 cr has Grown at 34.3% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 3.78 Cr

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Par Drugs & Che.

Profit After Tax (PAT) - Latest six months

At Rs 7.46 cr has Grown at -32.97%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is negative

PAT (Rs Cr)